Bioventus
Manufacturing · North Carolina, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
4721 Emperor Blvd Ste 100, Durham, North...Phone Number
(919) 474-6700Website
www.bioventus.comRevenue
$576.3 MillionStock Symbol
BVSIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
2
1
1
1
About Bioventus
Bioventus is a global leader of innovations for active healing. Through a combination of internal product development, product/business acquisition, and distribution agreements, we will bring to market products which address a growing need for clinically effective, cost efficient, minimally invasive medical treatments, that engage and enhance the bodys natural healing processes.Explore more
Bioventus Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bioventus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Bioventus has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Bioventus
Click to see if Bioventus had a recent Job posting/layoffs
Earning: See what the market has to say on Bioventus recently announced quarterly report
Product Launch: Get notified when Bioventus launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Bioventus, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Bioventus has new funding data
Check out if Bioventus is spiking on competitors!
Recommended Actions
Find VP level buyers at Bioventus
Find more new buyers
Compare Similar Companies to Bioventus
Compare insights from companies similar to Bioventus, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Bioventus
$576.3M
501-1,000
Public
$116M
2012
KM
Keith McBrideChief Technology Officer & Vice President, Research Development Pain & Restorative Therapies
Company Profile Activity
Activity Insights
Bioventus is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bioventus is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bioventus.
Bioventus financials insights
Gather financial insights about Bioventus, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Debt
$12M
2021
Stock Offering
$104M
Bioventus Tech Stack
A closer look at the technologies used by Bioventus
See more technologies
Most Recent Scoops
Open Position
Earnings
Bioventus has provided its H2 2025 outlook, expecting year-over-year revenue growth to increase by over 300 basis points compared to H1, driven equally by acceleration in Surgical Solutions including the timing shift from Q2 and revenue acceleration in PNS and PRP, with cash from operations expected to approximately double in H2 compared to H1.
Earnings, Forecasting, Finance
Person-Based
Earnings, Finance
Open Position
Open Position
Bioventus News & Media
Bioventus Inc. (BVS) Q2 2026 Earnings Call Transcript
Bioventus Inc. (BVS) Q2 2026 Earnings Call August 5, 2026 8:30 AM EDTCompany ParticipantsDavid Crawford - Vice President of Investor Relations &...Bioventus Q2 Earnings Call Highlights
Bioventus (NASDAQ:BVS) reported second-quarter 2026 revenue growth of 4% and reiterated its full-year financial outlook, citing double-digit expansion in its Pain Treatments business, continued debt reduction and increased investment in platelet-rich plasma, peripheral nerve stimulation, UltrasonicsBioventus Reports Second Quarter Financial Results
DURHAM, N.C., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today reported financial results for the three and six months ended June 27, 2026.Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026
DURHAM, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the second quarter of fiscal year 2026 before the market opens on Wednesday, August 5, 2026. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bioventus
Sign Up For FreeTo access detailed company insights
Bioventus is a global leader of innovations for active healing. Through a combination of internal product development, product/business acquisition, and distribution agreements, we will bring to market products which address a growing need for clinically effective, cost efficient, minimally invasive medical treatments, that engage and enhance the b... Read More
